M170 Pill — BROWN RECTANGLE, 19mm — Folic Acid

No photo available

Imprint	M170
Colour	BROWN
Shape	RECTANGLE
Size	19
Strength	VITAMIN A 4000 [iU];ASCORBIC ACID 120 mg;VITAMIN D 400 [iU];.ALPHA.-TOCOPHEROL ACETATE 22 [iU];THIAMINE 1.84 mg;RIBOFLAVIN 3 mg;NIACIN 20 mg;PYRIDOXINE HYDROCHLORIDE 10 mg;FOLIC ACID 1 mg;CYANOCOBALAMIN 12 ug;CALCIUM 200 mg;FERROUS FUMARATE 27 mg;ZINC 25 mg;COPPER 2 mg
Dosage form	Tablet
Manufacturer	Method Pharmaceuticals, LLC
NDC	58657-170
Schedule	—
Availability	Prescription only
Ingredients	VITAMIN A[VITAMIN A];ASCORBIC ACID[ASCORBIC ACID];VITAMIN D[CHOLECALCIFEROL];.ALPHA.-TOCOPHEROL ACETATE[.ALPHA.-TOCOPHEROL];THIAMINE[THIAMINE ION];RIBOFLAVIN[RIBOFLAVIN];NIACIN[NIACIN];PYRIDOXINE HYDROCHLORIDE[PYRIDOXINE];FOLIC ACID[FOLIC ACID];CYANOCOBALAMIN[CYANOCOBALAMIN];CALCIUM[CALCIUM];FERROUS FUMARATE[FERROUS CATION];ZINC[ZINC];COPPER[COPPER]

What does this imprint mean?

The imprint "M170" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Folic Acid

Uses and warnings

No boxed warning. Key warning: "administration of folic acid alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient" - doses above 0.1 mg daily may correct the blood picture while neurologic damage from B12 deficiency continues to progress, so B12 deficiency must be excluded before treating with folic acid alone. The label also notes folic acid may antagonize phenytoin's anticonvulsant action.

Folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood.

Read the full drug profile →